Jérémie Pichon
Université Paris-Saclay
14 Papers
Jérémie Pichon is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Medicine & Pulmonary hypertension. The author has an hindex of 3, co-authored 7 publications. Previous affiliations of Jérémie Pichon include French Institute of Health and Medical Research.
Chat about Author
Papers
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
Alice Huertas,Alice Huertas,David Montani,David Montani,Laurent Savale,Laurent Savale,Jérémie Pichon,Jérémie Pichon,Ly Tu,Ly Tu,Florence Parent,Florence Parent,Christophe Guignabert,Christophe Guignabert,Marc Humbert,Marc Humbert +15 more
TL;DR: Endothelial cell dysfunction and impaired microcirculatory function contribute markedly to life-threatening complications of COVID-19, such as venous thromboembolic disease and multiple organ involvement.
359
Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation.
Antoine Beurnier,Antoine Beurnier,Etienne-Marie Jutant,Etienne-Marie Jutant,Mitja Jevnikar,Mitja Jevnikar,Athénaïs Boucly,Athénaïs Boucly,Jérémie Pichon,Jérémie Pichon,Mariana Preda,Mariana Preda,Marie Frank,Jérémy Laurent,Christian Richard,Xavier Monnet,Jacques Duranteau,Anatole Harrois,Marie-Camille Chaumais,Marie-Camille Chaumais,Marie-France Bellin,Nicolas Noel,Sophie Bulifon,Sophie Bulifon,Xavier Jaïs,Xavier Jaïs,Florence Parent,Florence Parent,Andrei Seferian,Andrei Seferian,Laurent Savale,Laurent Savale,Olivier Sitbon,Olivier Sitbon,David Montani,David Montani,Marc Humbert,Marc Humbert +37 more
TL;DR: Asthma patients were not overrepresented among those with severe pneumonia due to SARS-CoV-2 infection who required hospitalisation, and the worst outcomes were observed mainly in patients with major comorbidities.
136
Association Between Initial Treatment Strategy and Long-term Survival in Pulmonary Arterial Hypertension
Athénaïs Boucly,Athénaïs Boucly,Laurent Savale,Laurent Savale,Xavier Jaïs,Xavier Jaïs,Fabrice Bauer,Emmanuel Bergot,Laurent Bertoletti,Antoine Beurnier,Antoine Beurnier,Arnaud Bourdin,Arnaud Bourdin,Hélène Bouvaist,Sophie Bulifon,Sophie Bulifon,C. Chabanne,Ari Chaouat,Vincent Cottin,Claire Dauphin,Bruno Degano,Pascal de Groote,Nicolas Favrolt,Yuanchao Feng,Delphine Horeau-Langlard,Mitja Jevnikar,Mitja Jevnikar,Etienne-Marie Jutant,Etienne-Marie Jutant,Zhiying Liang,Pascal Magro,Pierre Mauran,Pamela Moceri,Jean-François Mornex,Sylvain Palat,Florence Parent,Florence Parent,François Picard,Jérémie Pichon,Jérémie Pichon,Patrice Poubeau,Grégoire Prévot,Sébastien Renard,Martine Reynaud-Gaubert,Marianne Riou,Pascal Roblot,Olivier Sanchez,Andrei Seferian,Andrei Seferian,Cécile Tromeur,Jason Weatherald,Gérald Simonneau,Gérald Simonneau,David Montani,David Montani,Marc Humbert,Marc Humbert,Olivier Sitbon,Olivier Sitbon +58 more
TL;DR: In this paper, the relationship between the initial treatment strategy and survival in pulmonary arterial hypertension (PAH) remains uncertain, and the authors evaluate the long-term survival of patient with PAH.
Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment.
Charles Fauvel,O. Raitiere,Athénaïs Boucly,Pascal de Groote,Sébastien Renard,Jeanne Bertona,Nicolas Lamblin,Elise Artaud-Macari,Catherine Viacroze,Dominique Schleifer,Stéphane Dominique,Jérémie Pichon,Xavier Jais,David Montani,Olivier Sitbon,Laurent Savale,Marc Humbert,Fabrice Bauer +17 more
TL;DR: In this article , the echocardiographic tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/sPAP) ratio was used for noninvasive PAH risk assessment.
43
Functional respiratory complaints among COVID-19 survivors: a prospective cohort study
Antoine Beurnier,Laurent Savale,Xavier Jaïs,Romain Colle,Tài Pham,Luc Morin,Sophie Bulifon,Nicolas Noël,Athénaïs Boucly,Benoit Delbarre,Nathan Ebstein,Samy Figueiredo,Matthieu Gasnier,Anatole Harrois,Etienne-Marie Jutant,Mitja Jevnikar,Sophia Keddache,Annick Lecoq,Olivier Meyrignac,Florence Parent,Jérémie Pichon,Mariana Preda,Anne Roche,Andrei Seferian,Marie-France Bellin,Thomas Gille,Emmanuelle Corruble,Olivier Sitbon,Laurent Becquemont,Xavier Monnet,Marc Humbert,David Montani +31 more
TL;DR: In this paper , the proportion and characteristics of patients with functional respiratory complaints (FRCs) were assessed among 177 post-COVID-19 individuals who benefited from outclinic evaluation in the COMEBAC study (i.e., symptomatic and/or intensive care unit (ICU) survivors at 4 months).